Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Ovarian Neoplasms × niraparib × Clear all

Status

Completed 19 Unknown 11 Recruiting 10 Terminated 9 Active not recruiting 9 Withdrawn 5 Not yet recruiting 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Metastatic Castration-resistant Prostate Cancer 1

Interventions

olaparib 1 niraparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03025867 2017-04-17

Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer

Tesaro, Inc.

Approved for marketing

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡